Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis

Determinar el rendimiento diagnóstico del índice proteína/creatinina para identificar desenlaces materno-perinatales adversos en pacientes con preeclampsia, de acuerdo con una revisión sistemática de la literatura y metaanálisis. Se utilizaron las bases de datos PubMed, ClinicalKey, Cochrane y Web o...

Full description

Autores:: Echavez Cervantes, Israel David

Tipo de recurso:: https://purl.org/coar/resource_type/c_7a1f

Fecha de publicación:: 2024

Institución:: Universidad El Bosque

Repositorio:: Repositorio U. El Bosque

Idioma:

id	UNBOSQUE2_3ed8ee2c839d706be04927f10c883578
oai_identifier_str	oai:repositorio.unbosque.edu.co:20.500.12495/12852
network_acronym_str	UNBOSQUE2
network_name_str	Repositorio U. El Bosque
repository_id_str
dc.title.none.fl_str_mv	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
dc.title.translated.none.fl_str_mv	Creatinine protein index and adverse maternal-perinatal outcomes in pre-eclampsia: systematic review and meta-analysis
title	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
spellingShingle	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis Desenlace del embarazo Ratio proteína/creatinina Embarazo Pregnancy outcome Potein/creatinine ratio Pregnancy WQ 200
title_short	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
title_full	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
title_fullStr	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
title_full_unstemmed	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
title_sort	Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
dc.creator.fl_str_mv	Echavez Cervantes, Israel David
dc.contributor.advisor.none.fl_str_mv	Romero Infante , Ximena Carolina De la Hoz Valle , José Romero Infante, Ximena Carolina Sarmiento, Diana Piedad Sánchez, Sandra Milena
dc.contributor.author.none.fl_str_mv	Echavez Cervantes, Israel David
dc.subject.none.fl_str_mv	Desenlace del embarazo Ratio proteína/creatinina Embarazo
topic	Desenlace del embarazo Ratio proteína/creatinina Embarazo Pregnancy outcome Potein/creatinine ratio Pregnancy WQ 200
dc.subject.keywords.none.fl_str_mv	Pregnancy outcome Potein/creatinine ratio Pregnancy
dc.subject.nlm.none.fl_str_mv	WQ 200
description	Determinar el rendimiento diagnóstico del índice proteína/creatinina para identificar desenlaces materno-perinatales adversos en pacientes con preeclampsia, de acuerdo con una revisión sistemática de la literatura y metaanálisis. Se utilizaron las bases de datos PubMed, ClinicalKey, Cochrane y Web of Science entre el año 2005 y el 2022 utilizando palabras clave. Se incluyeron artículos de tipo transversal, de cohorte, casos y controles, y ensayos clínicos en idioma inglés. Métodos de evaluación y síntesis el estudio: se siguieron las recomendaciones Prisma y se registró en PROSPRO CRD42022373064 Los resultados se dividieron en resultados adversos tanto materno como fetales. Para la evaluación de calidad se usó la herramienta Quadas-2. El cálculo de sensibilidad y especificidad se realizó de forma agrupada por medio del método de efectos aleatorios de Mantel-Haenszel. Todos los resultados se presentaron con intervalos de confianza. También se calculó el área bajo la Curva Operador Receptor. La heterogeneidad se evaluó mediante la inconsistencia (I2) y el estadístico Q de Cochran.
publishDate	2024
dc.date.accessioned.none.fl_str_mv	2024-08-08T18:51:06Z
dc.date.available.none.fl_str_mv	2024-08-08T18:51:06Z
dc.date.issued.none.fl_str_mv	2024-01
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_7a1f
dc.type.local.spa.fl_str_mv	Tesis/Trabajo de grado - Monografía - Especialización
dc.type.coar.none.fl_str_mv	https://purl.org/coar/resource_type/c_7a1f
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/bachelorThesis
dc.type.coarversion.none.fl_str_mv	https://purl.org/coar/version/c_ab4af688f83e57aa
format	https://purl.org/coar/resource_type/c_7a1f
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/20.500.12495/12852
dc.identifier.instname.spa.fl_str_mv	instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv	reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv	repourl:https://repositorio.unbosque.edu.co
url	https://hdl.handle.net/20.500.12495/12852
identifier_str_mv	instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co
dc.relation.references.none.fl_str_mv	Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology and Obstetrics. 2019;145(S1):1–33. Wiwanitkit V. Periodic urinary protein creatinine ratio for predicting significant proteinuria in preeclampsia in different alternatives: Time effectiveness analysis. Arch Gynecol Obstet. 2010;281(3):571–3. Shreya G, Pranathi L, Kvitha V. Comparison of spot urine protein- creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. International Journal of Integrative Medical Sciences. 2015;2((1)):55–9. Shahbazian N, Hosseini-Asl F. A Comparison of Spot Urine Protein-Creatinine Ratio With 24-hour Urine Protein Excretion in Women With Preeclampsia. Kidney Diseases. 2008;2(3):127–31. Bhavana B, Usha M, Sunita G, Navjot B. Comparison of protein / creatinine ratio in single voided urine sample with 24 hours urine protein for estimation of proteinuria in pregnancy induced hypertension P : C. 2009;59(5):424–6. Kayatas S, Erdogdu E, Cakar E, Yilmazer V, Arinkan SA, Dayicioglu VE. Comparison of 24-hour urinary protein and protein-to-creatinine ratio in women with preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2013;170(2):368–71. Shahbazian N, Hosseini-Asl F. A comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. Iran J Kidney Dis. 2008;2(3):127–31. Cassiano ADN, Vitorino ABF, Oliveira SIM de, Silva MDLC da, Souza NML de, Souza NL de. Desfechos perinatais em gestantes com síndromes hipertensivas: revisão integrativa. Revista de Enfermagem da UFSM. 2020;10:e23. Xiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein‐creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. The Journal of Clinical Hypertension. 2022;(February):652–9. Ying W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal cardiovascular risk. J Am Heart Assoc. 2018;7(17):1–9. Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol [Internet]. 2022;226(2):S844–66. Available from: https://doi.org/10.1016/j.ajog.2021.11.1356 Pérez De Villa A, Álvarez A, Clavero EP, María Hernández Placía R. Preeclampsia: Characteristics and Consequences. Revista Finlay [Internet]. 2015;5(2):118–29. Available from: http://www.revfinlay.sld.cu/index.php/finlay/article/view/354 Ghossein-Doha C, Peeters L, Van Heijster S, Van Kuijk S, Spaan J, Delhaas T, et al. Hypertension after preeclampsia is preceded by changes in cardiac structure and function. Hypertension. 2013;62(2):382–90. Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol [Internet]. 2022;226(2):S786–803. Available from: http://dx.doi.org/10.1016/j.ajog.2021.12.001 Bolarte N, Loli S, Torres Y, Pezo-Pezo Armando, Gonzales M, Quispe A. Desenlaces neonatales adversos en gestantes con preeclampsia severa y sus factores asociados. Revista Cuerpo Medico [Internet]. 2019;12(2):113–8. Available from: www.ucalgary.ca/fenton/2013chart Kale PL, Fonseca SC. Intrauterine growth restriction, prematurity, and low birth weight: risk phenotypes of neonatal death, Rio de Janeiro State, Brazil. Cad Saude Publica. 2023;39(6). Sánchez-Cobo D, Copado-Mendoza DY, Valdespino-Vázquez MY, Rodríguez-Sibaja MJ, Acevedo-Gallegos S. Morphological changes in placentas of patients with preeclampsia or intrauterine growth restriction and interpretation of perinatal outcomes. Ginecol Obstet Mex. 2021 Nov 1;89(11):875–83. Alfonso L, Tascón M, Isabel D, Benítez C, Osorio MÁ, Isabel L, et al. Trabajos Originales Epidemiología de la prematuridad y sus determinantes , en una población de mujeres adolescentes y adultas de Colombia. 2016;81(5):372–80. Romero Infante XC, Uriel M, Porras Ramírez A, Rincón Franco S. Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high-risk population. Journal of Obstetrics and Gynaecology Research. 2021;47(2):765–73. De Haas S, Ghossein-Doha C, Geerts L, van Kuijk SMJ, van Drongelen J, Spaanderman MEA. Cardiac remodeling in normotensive pregnancy and in pregnancy complicated by hypertension: systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology. 2017;50(6):683–96. Lei T, Qiu T, Liao W, Li K, Lai X, Huang H, et al. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study. Reproductive Biology and Endocrinology. 2021 Dec 1;19(1). Shreya G, Pranathi L, Kvitha V. Comparison of spot urine protein- creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. International Journal of Integrative Medical Sciences. 2015;2((1)):55–9. P S, Bharathi D, V Kate N. The diagnostic accuracy of spot urine protein-creatinine ratio (UPCR) in quantification of proteinuria in women with preeclampsia. Indian Journal of Obstetrics and Gynecology Research. 2021 Mar 28;6(2):185–91. McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement. JAMA - Journal of the American Medical Association. 2018;319(4):388–96. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467–73. Urrutia G, Bonfill X. Declaración PRISMA : una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc). 2011;135(11):507–11. Cheung HC, Leung KY, Choi CH. Diagnostic accuracy of spot urine protein-to-creatinine ratio for proteinuria and its association with adverse pregnancy outcomes in Chinese pregnant patients with pre-eclampsia. Hong Kong Medical Journal. 2016 Jun 1;22(3):249–55. Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, et al. PIERS Proteinuria: Relationship With Adverse Maternal and Perinatal Outcome. Journal of Obstetrics and Gynaecology Canada. 2011;33(6):588–97. Nischintha S, Pallavee P, Ghose S. Correlation between 24-h urine protein, spot urine protein/creatinine ratio, and serum uric acid and their association with fetomaternal outcomes in preeclamptic women [Internet]. Available from: www.jnsbm.org Waugh J, Hooper R, Lamb E, Robson S, Shennan A, Milne F, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: A diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess (Rockv). 2017 Oct 1;21(61):1–90. Chadha A, Tayade S. Urinary Protein-to-Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria. Cureus. 2022;14(3). Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pre-eclampsia: How much matters? BJOG. 2005 Mar;112(3):280–5. Xiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein‐creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. The Journal of Clinical Hypertension. 2022;(February):652–9. Chung WH, To WWK. Outcome of pregnancy with new onset proteinuria and progression to pre-eclampsia: A retrospective analysis. Pregnancy Hypertens. 2018 Apr 1;12:174–7. Kuper SG, Tita AT, Youngstrom ML, Allen SE, Tang Y, Biggio JR, et al. Baseline renal function tests and adverse outcomes in pregnant patients with chronic hypertension. Obstetrics and Gynecology. 2016 Jul 1;128(1):93–103. Morikawa M, Mayama M, Saito Y, Nakagawa-Akabane K, Umazume T, Chiba K, et al. Severe proteinuria as a parameter of worse perinatal/neonatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2020 Jan 1;19:119–26. Kumari A, Chakrawarty A, Singh A, Singh R. Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country. J Pregnancy. 2014;2014. Cáceres MAM, Pedraza LCM, Mojica CHB, Martínez LAD. Maternal and fetal outcomes of pregnancies with hypertensive disorders: A cross-sectional study. Rev Chil Obstet Ginecol. 2020;85(1):14–23. Wiwanitkit V. Periodic urinary protein creatinine ratio for predicting significant proteinuria in preeclampsia in different alternatives: Time effectiveness analysis. Arch Gynecol Obstet. 2010;281(3):571–3. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology and Obstetrics. 2019;145(S1):1–33. Cassiano ADN, Vitorino ABF, Oliveira SIM de, Silva MDLC da, Souza NML de, Souza NL de. Desfechos perinatais em gestantes com síndromes hipertensivas: revisão integrativa. Revista de Enfermagem da UFSM. 2020;10:e23. Bravo-Grau S, Cruz JP. Estudios de exactitud diagnóstica: Herramientas para su Interpretación. Revista Chilena de Radiología. 2015;21(4):158–64. Cade TJ, Gilbert SA, Polyakov A, Hotchin A. The accuracy of spot urinary protein-to-creatinine ratio in confirming proteinuria in pre-eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2012 Apr;52(2):179–82. Martins-Costa SH, Vettorazzi J, Valério E, Maurmman C, Benevides G, Hemessath M, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: Maternal and perinatal outcomes. Hypertens Pregnancy. 2011;30(3):331–7.
dc.rights.en.fl_str_mv	Atribución-NoComercial-CompartirIgual 4.0 Internacional
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.uri.none.fl_str_mv	http://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.local.spa.fl_str_mv	Acceso abierto
dc.rights.accessrights.none.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Atribución-NoComercial-CompartirIgual 4.0 Internacional http://creativecommons.org/licenses/by-nc-sa/4.0/ Acceso abierto http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.none.fl_str_mv	application/pdf
dc.publisher.program.spa.fl_str_mv	Especialización en Medicina Materno-Fetal
dc.publisher.grantor.spa.fl_str_mv	Universidad El Bosque
dc.publisher.faculty.spa.fl_str_mv	Facultad de Medicina
institution	Universidad El Bosque
bitstream.url.fl_str_mv	https://repositorio.unbosque.edu.co/bitstreams/b75c3a21-9692-4f3c-b9be-e07ad1ae61e1/download https://repositorio.unbosque.edu.co/bitstreams/6b909505-6c91-484d-9ba7-afc6916642d9/download https://repositorio.unbosque.edu.co/bitstreams/dd1cae54-9656-44d3-8b1f-d5867ed5a0a2/download https://repositorio.unbosque.edu.co/bitstreams/58901a99-325f-4713-b245-8eb8e9f41d54/download https://repositorio.unbosque.edu.co/bitstreams/80e93eb6-7238-4512-a2e4-1a6cb395d5e1/download https://repositorio.unbosque.edu.co/bitstreams/05151131-bc56-4ad1-8db2-61a42285c1ce/download https://repositorio.unbosque.edu.co/bitstreams/ebb5ca57-583a-4cd0-9663-22df7eb76339/download
bitstream.checksum.fl_str_mv	1918891c4a7dbd0c74a7f80dad6dc7e6 3b6ce8e9e36c89875e8cf39962fe8920 17cc15b951e7cc6b3728a574117320f9 031d1f74a350dfa2af94bad61ce55879 cb13d33900e18aadb7b17cffe6f465f5 8824969d476eeeb300fb6b9dadb7ac2a e302ae707d1eb3e67db4c491966e49e7
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv	bibliotecas@biteca.com
_version_	1814100814466121728
spelling	Romero Infante , Ximena CarolinaDe la Hoz Valle , JoséRomero Infante, Ximena CarolinaSarmiento, Diana PiedadSánchez, Sandra MilenaEchavez Cervantes, Israel David2024-08-08T18:51:06Z2024-08-08T18:51:06Z2024-01https://hdl.handle.net/20.500.12495/12852instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coDeterminar el rendimiento diagnóstico del índice proteína/creatinina para identificar desenlaces materno-perinatales adversos en pacientes con preeclampsia, de acuerdo con una revisión sistemática de la literatura y metaanálisis. Se utilizaron las bases de datos PubMed, ClinicalKey, Cochrane y Web of Science entre el año 2005 y el 2022 utilizando palabras clave. Se incluyeron artículos de tipo transversal, de cohorte, casos y controles, y ensayos clínicos en idioma inglés. Métodos de evaluación y síntesis el estudio: se siguieron las recomendaciones Prisma y se registró en PROSPRO CRD42022373064 Los resultados se dividieron en resultados adversos tanto materno como fetales. Para la evaluación de calidad se usó la herramienta Quadas-2. El cálculo de sensibilidad y especificidad se realizó de forma agrupada por medio del método de efectos aleatorios de Mantel-Haenszel. Todos los resultados se presentaron con intervalos de confianza. También se calculó el área bajo la Curva Operador Receptor. La heterogeneidad se evaluó mediante la inconsistencia (I2) y el estadístico Q de Cochran.Especialista en Medicina Materno-FetalEspecializaciónTo determine the diagnostic performance of the protein/creatinine ratio to identify adverse maternal-perinatal outcomes in patients with preeclampsia, according to a systematic review of the literature and meta-analysis. The PubMed, ClinicalKey, Cochrane and Web of Science databases were used between 2005 and 2022 using keywords. Cross-sectional, cohort, case-control, and clinical trials in English were included. Methods of evaluation and synthesis of the study: Prisma recommendations were followed and registered in PROSPRO CRD42022373064. The results were divided into adverse maternal and fetal outcomes. The Quadas-2 tool was used for quality assessment. The calculation of sensitivity and specificity was performed in a pooled manner using the Mantel-Haenszel random effects method. All results were presented with confidence intervals. The area under the Receiver Operator Curve was also calculated. Heterogeneity was assessed using inconsistency (I2) and Cochran's Q statistic.application/pdfAtribución-NoComercial-CompartirIgual 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-sa/4.0/Acceso abiertoinfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Desenlace del embarazoRatio proteína/creatininaEmbarazoPregnancy outcomePotein/creatinine ratioPregnancyWQ 200Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisisCreatinine protein index and adverse maternal-perinatal outcomes in pre-eclampsia: systematic review and meta-analysisEspecialización en Medicina Materno-FetalUniversidad El BosqueFacultad de MedicinaTesis/Trabajo de grado - Monografía - Especializaciónhttps://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/resource_type/c_7a1finfo:eu-repo/semantics/bachelorThesishttps://purl.org/coar/version/c_ab4af688f83e57aaPoon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology and Obstetrics. 2019;145(S1):1–33.Wiwanitkit V. Periodic urinary protein creatinine ratio for predicting significant proteinuria in preeclampsia in different alternatives: Time effectiveness analysis. Arch Gynecol Obstet. 2010;281(3):571–3.Shreya G, Pranathi L, Kvitha V. Comparison of spot urine protein- creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. International Journal of Integrative Medical Sciences. 2015;2((1)):55–9.Shahbazian N, Hosseini-Asl F. A Comparison of Spot Urine Protein-Creatinine Ratio With 24-hour Urine Protein Excretion in Women With Preeclampsia. Kidney Diseases. 2008;2(3):127–31.Bhavana B, Usha M, Sunita G, Navjot B. Comparison of protein / creatinine ratio in single voided urine sample with 24 hours urine protein for estimation of proteinuria in pregnancy induced hypertension P : C. 2009;59(5):424–6.Kayatas S, Erdogdu E, Cakar E, Yilmazer V, Arinkan SA, Dayicioglu VE. Comparison of 24-hour urinary protein and protein-to-creatinine ratio in women with preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2013;170(2):368–71.Shahbazian N, Hosseini-Asl F. A comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. Iran J Kidney Dis. 2008;2(3):127–31.Cassiano ADN, Vitorino ABF, Oliveira SIM de, Silva MDLC da, Souza NML de, Souza NL de. Desfechos perinatais em gestantes com síndromes hipertensivas: revisão integrativa. Revista de Enfermagem da UFSM. 2020;10:e23.Xiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein‐creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. The Journal of Clinical Hypertension. 2022;(February):652–9.Ying W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal cardiovascular risk. J Am Heart Assoc. 2018;7(17):1–9.Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol [Internet]. 2022;226(2):S844–66. Available from: https://doi.org/10.1016/j.ajog.2021.11.1356Pérez De Villa A, Álvarez A, Clavero EP, María Hernández Placía R. Preeclampsia: Characteristics and Consequences. Revista Finlay [Internet]. 2015;5(2):118–29. Available from: http://www.revfinlay.sld.cu/index.php/finlay/article/view/354Ghossein-Doha C, Peeters L, Van Heijster S, Van Kuijk S, Spaan J, Delhaas T, et al. Hypertension after preeclampsia is preceded by changes in cardiac structure and function. Hypertension. 2013;62(2):382–90.Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol [Internet]. 2022;226(2):S786–803. Available from: http://dx.doi.org/10.1016/j.ajog.2021.12.001Bolarte N, Loli S, Torres Y, Pezo-Pezo Armando, Gonzales M, Quispe A. Desenlaces neonatales adversos en gestantes con preeclampsia severa y sus factores asociados. Revista Cuerpo Medico [Internet]. 2019;12(2):113–8. Available from: www.ucalgary.ca/fenton/2013chartKale PL, Fonseca SC. Intrauterine growth restriction, prematurity, and low birth weight: risk phenotypes of neonatal death, Rio de Janeiro State, Brazil. Cad Saude Publica. 2023;39(6).Sánchez-Cobo D, Copado-Mendoza DY, Valdespino-Vázquez MY, Rodríguez-Sibaja MJ, Acevedo-Gallegos S. Morphological changes in placentas of patients with preeclampsia or intrauterine growth restriction and interpretation of perinatal outcomes. Ginecol Obstet Mex. 2021 Nov 1;89(11):875–83.Alfonso L, Tascón M, Isabel D, Benítez C, Osorio MÁ, Isabel L, et al. Trabajos Originales Epidemiología de la prematuridad y sus determinantes , en una población de mujeres adolescentes y adultas de Colombia. 2016;81(5):372–80.Romero Infante XC, Uriel M, Porras Ramírez A, Rincón Franco S. Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high-risk population. Journal of Obstetrics and Gynaecology Research. 2021;47(2):765–73.De Haas S, Ghossein-Doha C, Geerts L, van Kuijk SMJ, van Drongelen J, Spaanderman MEA. Cardiac remodeling in normotensive pregnancy and in pregnancy complicated by hypertension: systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology. 2017;50(6):683–96.Lei T, Qiu T, Liao W, Li K, Lai X, Huang H, et al. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study. Reproductive Biology and Endocrinology. 2021 Dec 1;19(1).Shreya G, Pranathi L, Kvitha V. Comparison of spot urine protein- creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. International Journal of Integrative Medical Sciences. 2015;2((1)):55–9.P S, Bharathi D, V Kate N. The diagnostic accuracy of spot urine protein-creatinine ratio (UPCR) in quantification of proteinuria in women with preeclampsia. Indian Journal of Obstetrics and Gynecology Research. 2021 Mar 28;6(2):185–91.McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement. JAMA - Journal of the American Medical Association. 2018;319(4):388–96.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467–73.Urrutia G, Bonfill X. Declaración PRISMA : una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc). 2011;135(11):507–11.Cheung HC, Leung KY, Choi CH. Diagnostic accuracy of spot urine protein-to-creatinine ratio for proteinuria and its association with adverse pregnancy outcomes in Chinese pregnant patients with pre-eclampsia. Hong Kong Medical Journal. 2016 Jun 1;22(3):249–55.Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, et al. PIERS Proteinuria: Relationship With Adverse Maternal and Perinatal Outcome. Journal of Obstetrics and Gynaecology Canada. 2011;33(6):588–97.Nischintha S, Pallavee P, Ghose S. Correlation between 24-h urine protein, spot urine protein/creatinine ratio, and serum uric acid and their association with fetomaternal outcomes in preeclamptic women [Internet]. Available from: www.jnsbm.orgWaugh J, Hooper R, Lamb E, Robson S, Shennan A, Milne F, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: A diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess (Rockv). 2017 Oct 1;21(61):1–90.Chadha A, Tayade S. Urinary Protein-to-Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria. Cureus. 2022;14(3).Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pre-eclampsia: How much matters? BJOG. 2005 Mar;112(3):280–5.Xiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein‐creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. The Journal of Clinical Hypertension. 2022;(February):652–9.Chung WH, To WWK. Outcome of pregnancy with new onset proteinuria and progression to pre-eclampsia: A retrospective analysis. Pregnancy Hypertens. 2018 Apr 1;12:174–7.Kuper SG, Tita AT, Youngstrom ML, Allen SE, Tang Y, Biggio JR, et al. Baseline renal function tests and adverse outcomes in pregnant patients with chronic hypertension. Obstetrics and Gynecology. 2016 Jul 1;128(1):93–103.Morikawa M, Mayama M, Saito Y, Nakagawa-Akabane K, Umazume T, Chiba K, et al. Severe proteinuria as a parameter of worse perinatal/neonatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2020 Jan 1;19:119–26.Kumari A, Chakrawarty A, Singh A, Singh R. Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country. J Pregnancy. 2014;2014.Cáceres MAM, Pedraza LCM, Mojica CHB, Martínez LAD. Maternal and fetal outcomes of pregnancies with hypertensive disorders: A cross-sectional study. Rev Chil Obstet Ginecol. 2020;85(1):14–23.Wiwanitkit V. Periodic urinary protein creatinine ratio for predicting significant proteinuria in preeclampsia in different alternatives: Time effectiveness analysis. Arch Gynecol Obstet. 2010;281(3):571–3.Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology and Obstetrics. 2019;145(S1):1–33.Cassiano ADN, Vitorino ABF, Oliveira SIM de, Silva MDLC da, Souza NML de, Souza NL de. Desfechos perinatais em gestantes com síndromes hipertensivas: revisão integrativa. Revista de Enfermagem da UFSM. 2020;10:e23.Bravo-Grau S, Cruz JP. Estudios de exactitud diagnóstica: Herramientas para su Interpretación. Revista Chilena de Radiología. 2015;21(4):158–64.Cade TJ, Gilbert SA, Polyakov A, Hotchin A. The accuracy of spot urinary protein-to-creatinine ratio in confirming proteinuria in pre-eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2012 Apr;52(2):179–82.Martins-Costa SH, Vettorazzi J, Valério E, Maurmman C, Benevides G, Hemessath M, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: Maternal and perinatal outcomes. Hypertens Pregnancy. 2011;30(3):331–7.ORIGINALTrabajo de grado.pdfTrabajo de grado.pdfapplication/pdf1096099https://repositorio.unbosque.edu.co/bitstreams/b75c3a21-9692-4f3c-b9be-e07ad1ae61e1/download1918891c4a7dbd0c74a7f80dad6dc7e6MD55CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8899https://repositorio.unbosque.edu.co/bitstreams/6b909505-6c91-484d-9ba7-afc6916642d9/download3b6ce8e9e36c89875e8cf39962fe8920MD53LICENSElicense.txtlicense.txttext/plain; charset=utf-82000https://repositorio.unbosque.edu.co/bitstreams/dd1cae54-9656-44d3-8b1f-d5867ed5a0a2/download17cc15b951e7cc6b3728a574117320f9MD54Carta autorización.pdfapplication/pdf127312https://repositorio.unbosque.edu.co/bitstreams/58901a99-325f-4713-b245-8eb8e9f41d54/download031d1f74a350dfa2af94bad61ce55879MD56Acta de grado.pdfapplication/pdf184791https://repositorio.unbosque.edu.co/bitstreams/80e93eb6-7238-4512-a2e4-1a6cb395d5e1/downloadcb13d33900e18aadb7b17cffe6f465f5MD57TEXTTrabajo de grado.pdf.txtTrabajo de grado.pdf.txtExtracted texttext/plain79410https://repositorio.unbosque.edu.co/bitstreams/05151131-bc56-4ad1-8db2-61a42285c1ce/download8824969d476eeeb300fb6b9dadb7ac2aMD58THUMBNAILTrabajo de grado.pdf.jpgTrabajo de grado.pdf.jpgGenerated Thumbnailimage/jpeg2788https://repositorio.unbosque.edu.co/bitstreams/ebb5ca57-583a-4cd0-9663-22df7eb76339/downloade302ae707d1eb3e67db4c491966e49e7MD5920.500.12495/12852oai:repositorio.unbosque.edu.co:20.500.12495/128522024-08-09 03:06:51.241http://creativecommons.org/licenses/by-nc-sa/4.0/Atribución-NoComercial-CompartirIgual 4.0 Internacionalopen.accesshttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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

Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis

Publicaciones similares